|Chapter||Vaccine||Adverse Event||Epidemiologic Assessment||Mechanistic Assessment||Causality Conclusion|
|10||DT, TT, or aP containing||Immune Thrombocytopenic Purpura||Insufficient||Lacking||Inadequate|
NOTE: The measles-mumps-rubella; human papillomavirus; and diphtheria toxoid–, tetanus toxoid-, and acellular pertussis-containing vaccines have been abbreviated in the following ways: MMR; HPV; and DT, TT, and aP containing.
aThe committee attributes causation to the measles component of the vaccine.
bThe committee attributes causation to the rubella component of the vaccine.
cThe committee attributes causation to two particular vaccines used in three particular years in Canada.
dAlthough not originally charged to the committee by the sponsor, the committee considered this adverse event in its review of the literature.